Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.51 |
| ▸ | DPP4 | P27487 | 3/20 | 0.51 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.50 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.50 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.50 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | RRM1 | P23921 | 1/20 | 0.44 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14456838 | 1.00 | DPP7 (0.51) | DPP7DPP8DPP9DPP4GNAI3 | |
| SCHEMBL8528049 | 1.00 | DPP7 (0.51) | DPP7DPP8DPP9DPP4GNAI3 | |
| Hydrochloric Acid SCHEMBL8015391 | 0.98 | DPP7 (0.50) | DPP7DPP8DPP9DPP4GNAI3 | |
| Hydrochloric Acid SCHEMBL8015394 | 0.98 | DPP7 (0.50) | DPP7DPP8DPP9DPP4GNAI3 | |
| Hydrochloric Acid SCHEMBL8526234 | 0.98 | DPP7 (0.50) | DPP7DPP8DPP9DPP4GNAI3 | |
| SCHEMBL6014706 | 0.94 | GSR (0.57) | DPP7DPP8DPP9DPP4GNAI3 | |
| SCHEMBL19080648 | 0.94 | GSR (0.57) | DPP7DPP8DPP9DPP4GNAI3 | |
| SCHEMBL463468 | 0.94 | GSR (0.57) | DPP7DPP8DPP9DPP4GNAI3 | |
| SCHEMBL8403553 | 0.89 | DPP7 (0.48) | DPP7DPP8DPP9DPP4GNAI3 | |
| SCHEMBL20366099 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1940785-A2 | ACYCLIC 1,4-DIAMINES AND USES THEREOF | SmithKline Beecham Corporation (US) | 2008-07-09 | — | — | EP | claimed |
| WO-2007030761-A2 | ACYCLIC 1,4-DIAMINES AND USES THEREOF | SMITHKLINE BEECHAM CORPORATION (US) | 2007-03-15 | — | — | WO | claimed |
| EP-2897622-B1 | METHODS FOR TREATMENT OR PREVENTION OF DAMAGE RESULTING FROM RADIATION | SYNEDGEN INC (US) | 2021-04-21 | — | — | EP | disclosed |
| WO-2014197763-A1 | MOLECULAR DESIGN TOWARD DUAL-MODALITY PROBES FOR RADIOISOTOPE-BASED IMAGING (PET OR SPECT) AND MRI | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEAS SYSTEM (US) | 2014-12-11 | — | — | WO | disclosed |
| EP-1940785-A2 | ACYCLIC 1,4-DIAMINES AND USES THEREOF | SmithKline Beecham Corporation (US) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007030761-A2 | ACYCLIC 1,4-DIAMINES AND USES THEREOF | SMITHKLINE BEECHAM CORPORATION (US) | 2007-03-15 | — | — | WO | disclosed |
| US-5545624-A | USEFUL IN TREATING BACTERIAL OR MYCOPLASMIC INFECTIONS | PFIZER INC. (US) | 1996-08-13 | — | — | US | disclosed |